New online tool aims to help bladder cancer patients navigate tough treatment choices

NCT ID NCT05033067

Completed Knowledge-focused Sponsor: Icahn School of Medicine at Mount Sinai Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a new online tool called the Personal Patient Profile for Bladder Cancer (P3BC) in 24 patients who were facing bladder removal surgery. The tool provides personalized information, videos, and summaries to help patients talk with their doctors and prepare for recovery. The goal was to see if patients found the tool useful and acceptable, and to gather information for a larger future study.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Personal Patient Profile - Bladder Cancer (P3BC) decision aid
What this could lead to: If successful, this tool could help bladder cancer patients better communicate with their doctors and make more informed decisions about their treatment and recovery.
What could go wrong: This is a very small pilot study with only 24 participants, so results may not apply to everyone. The tool is still in early development and needs larger trials to confirm its benefits.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BLADDER CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

urinary bladder carcinoma Urinary Bladder Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BLADDER CANCER

Contacts and locations

Locations

Icahn School of Medicine at Mount Sinai

New York, New York, 10029, United States
University of Washington

Seattle, Washington, 98195-9472, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.